CancelGroupGroup 2Fill 1Page 1Group 13Group 9search iconStroke 4164 + Stroke 4165GroupPage 1Dark Line Arrowtwiiter icoPage 1Page 1

Download

Fast access to useful resources and the narrative report of this mapping site.

Resource Quicklinks

The following resources provide additional insight and information on the global landscape, including current challenges and opportunities, confronting TB care and IQA-SLD supply and access.

Narrative Analysis

Download the narrative analysis of this initiative's findings. This data is current as of September 2017.

About the Tool

The TB Drug Access Atlas is a data-driven tool built with the goal to help inform decision-making, reduce programmatic redundancy where appropriate, take advantage of shared strengths, and address clear gaps in the areas of intervention where needed. Learn more about the Atlas, and view a tutorial for how to use the site.

Learn More

Methodology

The research team used a combination of publicly available information and reports to populate project drivers, regions of work, project budgets, partner organizations, project contacts, milestone dates, and activity timelines. Over the course of the next two months, all project leads were contacted requesting their participation in the mapping exercise. Each contact who agreed to participate was first asked to fill out a Qualtrics survey intended to summarize project goals, approximate budget range, primary funders, activity timeline, partner organizations, regions where the project is working, and other projects they might be aware of working in a similar space. Participants were also asked to participate in a 30-45 minute telephone interview with a member of the research team. Interviews were attended by at least two members of the research team, one leading the interview and the other recording details of the interview.

Learn More

Resources

The following resources provide additional insight and information on the global landscape, including current challenges and opportunities, confronting TB care and IQA-SLD supply and access.

WHO TB Report – 2016

UnitAid TB Medicines Landscape

View All

Made Possible By:

The TB Drug Atlas is made possible through the support of the Lilly Global Health Partnership




Lilly Global Health Logo

The Lilly Global Health Partnership is ambitiously working to increase access to quality health care and to improve long-term health for millions of people worldwide.

Through investments in people, medicines and health systems, Lilly aims to reach 30 million people in resource-limited settings annually by 2030. The cornerstone of this goal - known as Lilly 30x30 - is a new five-year, $90 million investment in the Lilly Global Health Partnership, which will improve access to treatment for diabetes, cancer and tuberculosis.


Contact

Have a question or feedback? Please contact us and we'll get right back in touch.

Contact Us